Longitudinal assessment of D-dimer and plasminogen activator inhibitor type-1 plasma levels in pregnant women with risk factors for preeclampsia

Lucena, Flávia Campos, Lage, Eura Martins, Teixeira, Patrícia Gonçalves, Barbosa, Alexandre Simões, Diniz, Rejane, Lwaleed, Bashir, Talvani, André, Alpoim, Patrícia Nessralla, Perucci, Luiza Oliveira and Dusse, Luci Maria Sant Ana (2019) Longitudinal assessment of D-dimer and plasminogen activator inhibitor type-1 plasma levels in pregnant women with risk factors for preeclampsia. Hypertension in Pregnancy, 38 (1), 58-63. (doi:10.1080/10641955.2019.1577435).

Abstract

Objective: Investigating D-Dimer/D-Di and plasminogen activator inhibitor type-1/PAI-1 levels throughout gestation in women with preeclampsia/PE risk factors. Methods: D-Di and PAI-1 plasma levels were determined in 28 women at 12–19, 20–29, 30–34 and 35–40 weeks of gestation. Results: D-Di was lower at 12–19 weeks and higher at 30–34 weeks in women who developed PE versus who did not develop it. D-Di increased throughout gestation in both groups, peaking earlier in pregnant women who developed PE versus who did not develop it. PA1-1 increased across gestation, but it didn’t differ between groups. Conclusion: D-Di was able to discriminate these groups of women at 12–19 and 30–34 weeks of gestation.

This record has no associated files available for download.

Contributors

Download statistics